Neuroendocrine Tumors of the Esophagus: State of the Art in Diagnostic and Therapeutic Management
- 27 June 2017
- journal article
- review article
- Published by Springer Nature in Journal of Gastrointestinal Cancer
- Vol. 48 (4) , 299-304
Abstract
Introduction Neuroendocrine tumors (NETs) are a heterogeneous group of neoplasms composed of cells containing dense-core neuroendocrine secretory granules in their cytoplasm. NETs of the esophagus are exceedingly uncommon, with a parallel absence of data published on clinical features, prognosis, and proposed treatment strategies. Methods As relevant classification is not well-established, knowledge acquired in NETs of lung and gastrointestinal sites usually guides esophageal NET management. Associated subtypes are divided based upon shared neuroendocrine features into small and large cell NET, typical and atypical carcinoid. Results Common presenting symptoms include dysphagia, abdominal discomfort, weight loss, melena, and on occasion, signs of carcinoid syndrome. Endoscopic findings describe a polypoid, nodular elevated lesion with an overlying surface depicted as mostly smooth and glistening. Disease metastasis is assessed using anatomical imaging, including computed tomography (CT), endoscopic ultrasonography (EUS), and positron emission tomography (PET)-CT. Prognosis is influenced by the extent of lymph node metastasis and potential lymphovascular invasion. Furthermore, proliferative activity, estimated using mitotic count or Ki-67 immunostaining, has been suggested as a significant prognostic parameter. Conclusion Therapeutic approach depends on clinical staging. Nevertheless, currently, a specific treatment algorithm for esophageal NETs has not been elucidated. Endoscopic resection has been proposed in NETs less than 1 cm in size with absence of regional lymph node metastasis, while surgical excision combined with adjuvant chemotherapy remains the treatment of choice.Keywords
Funding Information
- None
This publication has 47 references indexed in Scilit:
- Mixed adeno(neuro)endocrine carcinoma arising from the ectopic gastric mucosa of the upper thoracic esophagusWorld Journal of Surgical Oncology, 2013
- Second-line chemotherapy for refractory small cell neuroendocrine carcinoma of the esophagus that relapsed after complete remission with irinotecan plus cisplatin therapy: Case report and review of the literatureOncology Letters, 2012
- Endoscopic submucosal dissection for foregut neuroendocrine tumors: An initial studyWorld Journal of Gastroenterology, 2012
- Treatment and prognosis of limited disease primary small cell carcinoma of esophagusDiseases of the Esophagus, 2010
- Small cell carcinomas in gastrointestinal tract: immunohistochemical and clinicopathological featuresJournal of Clinical Pathology, 2010
- Impact of 18F‐fluorodeoxyglucose positron emission tomography in the staging and treatment response assessment of extra‐pulmonary small‐cell cancerJournal of Medical Imaging and Radiation Oncology, 2010
- Concurrent chemoradiation alone with curative intent for limited-disease small-cell esophageal cancer in nine Japanese patientsDiseases of the Esophagus, 2009
- Gastroenteropancreatic neuroendocrine tumoursThe Lancet Oncology, 2008
- Small cell carcinoma of the esophagusSaudi Journal of Gastroenterology, 2008
- Primary small cell carcinoma of the esophagus: clinicopathological and immunohistochemical features of 21 casesBMC Cancer, 2007